No Data
No Data
Cosmo Bio To Go Ex-Dividend On June 27th, 2024 With 14 JPY Dividend Per Share
June 26th (Japan Standard Time) - $Cosmo Bio(3386.JP)$ is trading ex-dividend on June 27th, 2024.Shareholders of record on June 30th, 2024 will receive 14 JPY dividend per share. The ex-dividend date
Japan M&A Center Holdings, Koss Corp, Cosmo Bio, etc.
<2127> Japan M&A Center Holdings Baillie Gifford & Co's shareholding ratio increased from 8.64% to 10.28% as of June 10, 2024; <3223> SL Dee Co., Ltd.'s Nobuki Ban's shareholding ratio decreased from 5.43% to 1.60% as of June 12, 2024; <3386> Cosmo Bio Co., Ltd. (Koss Corp) Hikari Communications share.
The era of 5 million dementia patients has arrived, promising stocks and overall verification of social issues. <Stock Top Feature>
The second meeting of the conference for promoting dementia policies was held on May 8th, and it was estimated that the number of dementia patients would reach 5.231 million in 2030 (4.432 million in 2022). The "Basic Law on Dementia" was enacted in January of this year to realize a society in which people with dementia can live together, and discussions are underway to formulate a basic plan. However, to overcome the era of 5 million dementia patients, it is essential to utilize both policies and treatments, as well as technology. Therefore, this time, we focus on related stocks that confront social issues.
Sanyo Kasei --- Starts selling “EXORPTION (R),” an extracellular vesicle (EV) purification kit such as exosomes
Sanyo Chemical Industries (4471) announced on the 13th that it will start selling “EXORPTION (R).” “EXORPTION (R)” is a purification kit that can recover extracellular vesicles (EVs) such as exosomes in a short time with high purity and high yield with simple operation. Sales of this kit began in 2024/5 through Cosmo Bio <3386> and Takara Bio <4974>. “EXORPTION (R)” is a special hydrogel bee that absorbs body fluids
Cosmo Bio: Confirmation letter
Cosmo Bio: Quarterly Report - 42nd Quarter 1 (2024/01/01 to 2024/03/31)
No Data